Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 138
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
From Approvals to Appointments: Who Pays for Psychedelic Therapy, and How?
Ukraine’s Invisible Front: The PTSD Turn in Europe
Weekly Psychedelic Policy Briefing, Nov 13, 2026
Breaking: Helus’ Deuterated Psilocin Hits Primary Endpoint in First Phase 3
Podcast: Compass Files Psilocybin Application with FDA, U.S. Government Taps Mark Cuban to Develop Ibogaine, Psychedelics After the Midterms
Reunion Neuroscience Provides Business Update and Reports Fiscal Third Quarter 2023...
FILAMENT HEALTH ANNOUNCES SECOND PSILOCYBIN SUPPLY AGREEMENT WITH THE CENTRE FOR...
Israel-Based Clearmind Medicine to Present at The OurCrowd Global Investor Summit...
Silo Pharma Announces Filing of Patent for Treatment of Alzheimer’s
MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT
Psychedelics Weekly – AIMS vs. the DEA: An Update on the...
Establishing the Psychedelic Research Center Consortium
Key Psychedelic Research Themes in 2022
PT388 – Vital Psychedelic Conversations
Bright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent...
Load more